Examkin

Soru

Zorluk: OrtaMonitoring and Treatment Evaluation

A 4242-year-old woman with a history of bipolar I disorder is evaluated during a routine follow-up visit. She has been stable and euthymic on a fixed dose of lithium carbonate for the past 33 years. Two weeks ago, she was diagnosed with primary hypertension by her primary care physician and started on hydrochlorothiazide. Today, she reports feeling well and has no new symptoms. Her blood pressure is 126/82126/82 mmHg, and her pulse is 7272/min. Physical examination reveals no abnormalities, and there is no resting tremor.

Which of the following is the most appropriate next step in management?

  1. Measurement of serum lithium concentrationCevap
  2. B
    Substitution of hydrochlorothiazide with lisinopril
  3. C
    Measurement of serum thyroid-stimulating hormone concentration
  4. D
    2424-hour urine collection for volume and osmolality
  5. E
    Continuation of current management with routine follow-up

Cevap

The most appropriate next step in management is the measurement of serum lithium concentration.
The correct answer is the measurement of serum lithium concentration. Lithium has a narrow therapeutic index (0.60.6 to 1.21.2 mEq/L). Thiazide diuretics, such as hydrochlorothiazide, induce mild volume depletion and sodium loss. This physiological state triggers a compensatory increase in sodium reabsorption in the proximal convoluted tubule of the kidney. Because lithium is reabsorbed via the same transport mechanisms as sodium, the proximal reabsorption of lithium significantly increases. This can rapidly elevate serum lithium levels into the toxic range, even if the patient is currently asymptomatic. Therefore, when a thiazide diuretic is initiated in a patient stabilized on lithium, a serum lithium level must be checked within 11 to 22 weeks so that the lithium dose can be proactively adjusted (typically reduced) to prevent neurologic toxicity.

Adım Adım Çözüm

1
Identify the patient's current medication regimen and recent changes.
The patient is on chronic lithium therapy and was recently started on hydrochlorothiazide for hypertension.
Recognizing medication changes is critical for identifying potential adverse drug-drug interactions.
2
Analyze the pharmacokinetic interaction between lithium and hydrochlorothiazide.
Thiazide diuretics induce sodium depletion, which leads to a compensatory increase in sodium reabsorption in the proximal tubule. Because lithium is handled similarly to sodium, its reabsorption is also increased.
Increased lithium reabsorption can rapidly elevate serum lithium concentrations to toxic levels.
3
Determine the necessary monitoring or intervention based on this interaction.
A serum lithium concentration should be measured to ensure it remains within the narrow therapeutic index.
Proactive monitoring allows for timely dose adjustment of lithium before the onset of clinical toxicity.

Anahtar Kavram

Thiazide diuretics decrease the renal clearance of lithium, leading to increased serum lithium concentrations and risk of toxicity. Therefore, serum lithium levels must be monitored closely when a thiazide diuretic is initiated.

Alternatif Yöntem

If a patient on lithium requires a new antihypertensive agent and frequent lab monitoring is not feasible, initiating a calcium channel blocker (like amlodipine) is often preferred as it has minimal impact on lithium clearance compared to thiazides, ACE inhibitors, or ARBs.
Tahmini Süre:1m 0s
Bu soruyu puanla

Konular

Monitoring and Treatment Evaluation

Bu konudan daha fazla soru